Forget being sneezed on: Government scientists are deliberately giving dozens of volunteers the flu by squirting the live virus straight up their noses. It may sound bizarre, but the rare type of research is a step in the quest for better flu vaccines. It turns out that how the body fends off influenza remains something of a mystery.
In a news release, Tennessee Economic and Community Development Commissioner Bill Hagerty says the company will invest $25 million in manufacturing equipment and building and infrastructure improvements in Morristown.
The National Newspaper Publishers Association and National Association of Black Owned Broadcasters argued that the ads should be disseminated through their outlets because the black community has been disproportionally targeted by tobacco companies and harmed by smoking.
Did you ever wonder who is involved in the creation and promulgation of these standards? Most people have no idea – and it’s an incredibly important piece of business intelligence to have, since those at the table where standards are developed have the opportunity to shape the specifications and market acceptance of products and systems for every industry.
The laboratory test from Affymetrix detects variations in patients' chromosomes that are linked to Down syndrome, DiGeorge syndrome and other developmental disorders. About 2 to 3 percent of U.S. children have some sort of intellectual disability, according to the National Institutes of Health.
Sandwiched in this lens are two twinkling glitter-specks loaded with tens of thousands of miniaturized transistors. It's ringed with a hair-thin antenna. Together these remarkable miniature electronics can monitor glucose levels in tears of diabetics and then wirelessly transmit them to a handheld device.
Johnson & Johnson is being offered $4.15 billion by The Carlyle Group for its Ortho-Clinical Diagnostics business.The New Brunswick, N.J., company has until the end of March to decide whether to accept the offer.
A federal jury ruled that medical device maker Medtronic infringed on a patent held by Edwards Lifesciences and ordered Medtronic to pay its competitor about $390 million in damages. Edwards said it will seek a permanent injunction to stop Medtronic's CoreValve system from going on sale in the U.S.
CareFusion Corp. has agreed to pay $40.1 million to settle allegations it paid kickbacks and promoted its medical technology products for uses not approved by the Food and Drug Administration. The Justice Department announced the settlement Thursday with the California-based company of a whistleblower lawsuit unsealed in U.S. District Court in Kansas.
The University of Minnesota is recruiting students for a new master's program in medical device innovation. The program is under the Technological Leadership Institute, part of the university's College of Science and Engineering. The new curriculum is aimed at preparing students for managing the challenges of the medical device industry.
The businesses, which had combined annual revenue of about $250 million in 2013, will become part of GE Healthcare's life sciences unit. GE said that the transaction allows it to expand its offering of technologies for the discovery and manufacturing of new medicines, vaccines and diagnostics in its life sciences business.
Vaccines did not cause the deaths of nine children shortly after they were inoculated for hepatitis in a Chinese government program and no links have been found in eight other cases still being investigated, health officials said Friday after safety concerns arose.
The probe was launched after provincial and health authorities separately reported that since November, about a half-dozen babies died shortly after receiving hepatitis B vaccine made by Biokangtai. One case has been ruled out while the others are still being investigated.
Airgas Inc., which sells gases and equipment to hospitals and industrial companies, said Friday that it is increasing prices on helium by 20 percent because it is costing it more to obtain and distribute the gas. The company said the Bureau of Land Management, which supplies a significant portion of helium in the U.S., is charging helium refiners more for the gas.
Jazz will make a tender offer of $57 per share for the Italian company, about a 2 percent premium to Gentium's closing stock price in the U.S. on Thursday. Gentium develops drugs to treat a variety of rare diseases and conditions, including orphan vascular diseases related to cancer treatments.
Not since Henry Ford introduced the assembly line has there been such a watershed moment in manufacturing. Three-dimensional printing and additive manufacturing (3DP/AM) are rapidly expanding manufacturing capabilities and product commercialization.
Need a hand lifting something? A robotic device invented by University of Pennsylvania engineering students can help its wearer carry an additional 40 pounds.Titan Arm looks and sounds like part of a superhero's costume. But its creators say it's designed for ordinary people.
A French businessman who sold tens of thousands of breast implants filled with industrial-grade silicone and prone to leaks was convicted of fraud on Tuesday and sentenced to the maximum four years in prison.
A few patients with one type of leukemia were given this one-time, experimental therapy several years ago and some remain cancer-free today. Now, at least six research groups have treated more than 120 patients with many types of blood and bone marrow cancers, with stunning results.
A truck carrying an extremely dangerous radioactive substance has been stolen in central Mexico, the U.N. nuclear agency said Wednesday.The International Atomic Energy Agency said the truck was carrying cobalt-60, used for radiotherapy treatment to combat cancer.
Federal health regulators are warning the public that certain cardiac defibrillators recalled by Philips Healthcare may fail to deliver a needed shock in an emergency.Defibrillators are used by emergency responders and others to restore normal heart function in people suffering a heart attack.
Genetic testing company 23andMe is facing a class action lawsuit alleging that the Silicon Valley startup misled customers with advertising for its personalized DNA test kit. The test is marketed as a tool to help users predict their risk of developing various diseases.
In a warning letter posted online Monday, FDA regulators say that the Silicon Valley company has not shown that its tests are safe or effective despite "more than 14 face-to-face and teleconference meetings" and "hundreds of email exchanges."
With the Affordable Care Act pushing more long-term treatment to be done at home, and patients demanding an increased level of autonomy when it comes to treating their conditions, many devices that were once only operated by skilled, educated technicians or physicians are now in the hands of relatively inexperienced patients.
Johnson & Johnson said late Tuesday that it will pay $2.5 billion to settle thousands of lawsuits brought by hip replacement patients who accuse the company of selling faulty implants that led to injuries and additional surgeries.